Clinique du Fief de Grimoire
Poitiers, 86000, France
NCT Number: NCT07267572
The diagnosis of breast cancer in a woman can cause major psychological trauma with many destructive effects in all areas of life.
Dealing with this profound distress is often difficult, sometimes poorly defined between different professionals (psychiatrists, psychologists, psychotherapists, proponents of alternative therapies), leading to highly variable and difficult-to-measure results.
Since the first French cancer plan (2003/2007), facilities offering cancer care have been legally required to have a notification and support system in place. This consists of offering patients a range of supportive care throughout their cancer treatment (psychotherapy, physical activities, dietetics, pain management, etc.).
In recent years, logotherapy has been offered as part of psychological care. Logotherapy is a form of psychotherapy based on meaning, which has been offered for many years and aims to help patients create or discover meaning in their lives. Meaning serves as motivation to continue living despite illness by placing this ordeal in the context of existence.
Suffering can thus be transformed into opportunity. The use of logotherapy gives the suffering person the ability to take an active part in their treatment and helps them to mobilize their personal resources to keep the disease at bay, stabilize it, or cure it.
Several studies conducted on women with breast or gynecological cancer have shown that logotherapy can reduce the symptoms of traumatic stress and increase their ability to find meaning in their lives. However, these studies have certain limitations because they are not randomized.
In order to evaluate the short- and medium-term benefits of logotherapy in patients diagnosed with primary breast cancer, we propose a prospective, comparative, randomized study.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Poitiers, 86000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Female patient:
Exclusion criteria
Female patient:
Logotherapy consists of four individual sessions conducted by a nurse who is specialized and certified in logotherapy, at a rate of one session every two weeks, lasting approximately 60 minutes.
Supportive care offered as part of the patient notification process following the diagnosis of breast cancer.
Time frame: 10 weeks
Anxiety score of the Hospital Anxiety and Depression Scale (HADS) score. The HADS is a validated self-administered questionnaire consisting of 14 items allowing patients to assess their mood over the past week. It is composed of two parts (anxiety and depression) The result ranges from 0 to 21.
Time frame: 10 weeks
Depression score of the HADS. This score will be analysed on a second step (two-step hierarchical sequential analysis) only if a significative difference is observable on the first step (anxiety).
Time frame: Baseline, 10 weeks, 6 months and 9 months
HADS score (anxiety and depression).
Time frame: Baseline, 10 weeks, 6 months and 9 months
Perceived Stress Scale (PSS) score. It is a validated self-administered questionnaire, comprising 10 questions assessing a patient's individual stress level. The result is expressed in a score between 0 (no perceived stress) and 40 (high perceived stress)
Time frame: Baseline, 10 weeks, 6 months and 9 months
EORTC QJQ-C30. It is a general self-administered questionnaire comprising 30 questions to assess the quality of life of cancer patients participating in clinical trials. The result is expressed in a score between 0 and 100.
Time frame: Over 9 months
Number of consultations with a specialist in psychotherapy in relation to breast cancer management.
Time frame: 10 weeks, 6 months and 9 months
Number of anxyolitic treatments (type, dose and indication)
Time frame: 10 weeks, 6 months and 9 months
Number of anti-depressant treatments (type, dose and indication)
Contact information is provided by the study sponsor or research team.
Charlène PY
CONTACT
Emmanuelle MALHOMME
CONTACT
Elsan
Other
Randomized, Comparative Study to Evaluate the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer
Acronym: AELO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619534
Breast Cancer, Breast Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07735897
Breast Cancer, Breast Diseases
Seoul, Sondpagu, South Korea
View Trial DetailsNCT07739563
Behavior, Breast Cancer
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07737132
Breast Cancer, Breast Diseases
View Trial Details